Valence8 Us LP Relay Therapeutics, Inc. Transaction History
Valence8 Us LP
- $241 Billion
- Q3 2024
A detailed history of Valence8 Us LP transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Valence8 Us LP holds 26,200 shares of RLAY stock, worth $117,900. This represents 0.08% of its overall portfolio holdings.
Number of Shares
26,200Holding current value
$117,900% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding RLAY
# of Institutions
204Shares Held
156MCall Options Held
207KPut Options Held
40K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$126 Million1.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.5MShares$65.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$47.4 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY9.25MShares$41.6 Million5.09% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.38MShares$33.2 Million0.88% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $541M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...